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ChordinExtracellular regulation of growth factor signaling is a key event for embryonic patterning. Heparan sulfate
proteoglycans (HSPG) are among the molecules that regulate this signaling during embryonic development.
Here we study the function of syndecan1 (Syn1), a cell-surface HSPG expressed in the non-neural ectoderm
during early development of Xenopus embryos. Overexpression of Xenopus Syn1 (xSyn1) mRNA is sufﬁcient
to reduce BMP signaling, induce chordin expression and rescue dorso-ventral patterning in ventralized
embryos. Experiments using chordin morpholinos established that xSyn1 mRNA can inhibit BMP signaling in
the absence of chordin. Knockdown of xSyn1 resulted in a reduction of BMP signaling and expansion of the
neural plate with the concomitant reduction of the non-neural ectoderm. Overexpression of xSyn1 mRNA in
xSyn1 morphant embryos resulted in a biphasic effect, with BMP being inhibited at high concentrations and
activated at low concentrations of xSyn1. Interestingly, the function of xSyn1 on dorso-ventral patterning and
BMP signaling is speciﬁc for this HSPG. In summary, we report that xSyn1 regulates dorso-ventral patterning
of the ectoderm through modulation of BMP signaling.© 2009 Elsevier Inc. All rights reserved.IntroductionTissue patterning in early embryonic development is speciﬁed by
morphogen gradients, among which are members of the BMP, Wnt
and Hh families. A key role for extracellular components in
morphogen gradient formation and interpretation has been demon-
strated in ﬂy and vertebrate embryos (Freeman and Gurdon, 2002;
Lander et al., 2002; Tabata and Takei, 2004). The current under-
standing of extracellular regulation of BMP signaling is particularly
well advanced, with many of the evolutionary conserved proteins that
directly interact with BMP having been identiﬁed. This set of
molecules play a key role in the establishment of a very robust
extracellular gradient of BMP signaling that patterns the germ layers
in vertebrate and invertebrate embryos (De Robertis, 2006; O'Connor
et al., 2006). Interestingly, many BMP binding proteins such as
chordin/sog, twisted gastrulation (Tsg) and crossveinless2 (Cv2) have
dual effects on BMP signaling and they can promote or inhibit BMP
activity depending on the cellular and molecular context (De Robertis
et al., 2000; Larraín et al., 2001; Ambrosio et al., 2008; Bier, 2008;
Serpe et al., 2008). This dual function could be useful for creation of
sharp borders along embryonic territories (De Robertis et al., 2000;
Larraín et al., 2001).
Heparan sulfate proteoglycans (HSPG) also play an important
function in extracellular regulation of growth factor signaling during
embryonic development (Lin, 2004). HSPG are cell-surface andl rights reserved.extracellular matrix (ECM) components formed by a core protein
with covalently attached heparan sulfate (HS) glycosaminoglycan
(GAGs) chains. HS are linear polysaccharide chains made of repeated
disaccharide units composed of glucuronic acid and a glucosamine
derivative. Depending on its core protein, HSPG can be classiﬁed in
different families, including two cell-surface proteoglycans that are
conserved from ﬂies to vertebrates, glypicans and syndecans (Syn).
Glypicans are GPI-anchored, while Syn are type I transmembrane
proteins consisting of a single transmembrane domain and a short
conserved intracellular domain (Carey,1997). Themajority of theGAGs
added to glypicans and Syn ectodomains are of the HS type, although
modiﬁcations of Syn1 and 4 with chondroitin sulfate chains (CS) have
been described (Carey, 1997). One Syn and two glypicans (dally and
dally-like protein) genes are encoded in the Drosophila genome and
four Syn and at least six glypicans have been identiﬁed in vertebrates.
HS chains bind to a great variety of growth factors including
members of the TGFβ, Hh, Wnt and FGF families and are responsible
for many HSPG functions (Lin, 2004). The role of HSPG, particularly of
Syn1 in FGF signaling has been extensively studied. HS chains can have
a biphasic effect on FGF signaling; they can increase FGF binding to its
cognate receptor or can reduce growth factor bioavailability through
sequestration, modulation of ligand stability and/or localization (Mali
et al., 1993; Carey, 1997; Larraín et al., 1998; Esko and Selleck, 2002;
Hacker et al., 2005; Bishop et al., 2007). A similar biphasic effect for
HSPG on Shh activity has been described (Carrasco et al., 2005;
Beckett et al., 2008).
Even though most HSPG functions are attributed to its HS chains,
the core proteins also have important roles in cell–cell signaling
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epithelial mitogen lacritin through extracellular domains on its core
protein (Beauvais et al., 2004; Ma et al., 2006; McQuade et al., 2006).
In addition, Syn2 and 4 control cell adhesion through extracellular
domains depleted of GAG chains (McFall and Rapraeger, 1998; Park et
al., 2002). In the same venue, the core protein of glypican3 interacts
and regulates Shh activity even when the GAG attachment sites are
mutated (Capurro et al., 2005, 2008). Similarly, a glypican4 GAG
mutant can regulate non-canonical Wnt signaling and gastrulation
(Ohkawara et al., 2003) and a dally GAG mutant rescued some
phenotypes of dally ﬂy mutants (Kirkpatrick et al., 2006). In summary,
HSPG regulates growth factor signaling through both GAG-dependent
and -independent mechanisms.
Genetic studies in ﬂies, worms, zebraﬁsh and mice revealed the
importance of HSPG in cell signaling and morphogen gradient
formation during early development, organ formation and adult
physiology (Lin, 2004; Hacker et al., 2005; Bulow and Hobert, 2006;
Bishop et al., 2007). In the majority of these studies, genes encoding
for HS biosynthetic enzymes were mutated and the effect on
embryonic development analyzed. HS biosynthetic enzymes are
common for all members of the HSPG families; therefore, the
experimental approach mentioned was not informative enough to
elucidate the functions of each speciﬁc proteoglycan. In order to
address the role of each HSPG, the effect of mutations on genes
encoding the core proteins has been studied, revealing that glypicans
and its ﬂy orthologues (dally, dally-like protein) regulate Wg, Shh, FGF
and BMP/dpp signaling (Topczewski et al., 2001; Lin, 2004; Hacker et
al., 2005; Song et al., 2005; Capurro et al., 2008).
To date, no function for Syn1 in early development has been
reported. At later stages Syn1 is involved in axon pathﬁnding in ﬂies
and worms (Johnson et al., 2004; Steigemann et al., 2004; Rhiner et
al., 2005) and is required for re-epithelialization after wound
healing in adult mice (Stepp et al., 2002). In addition, Wnt1 is
unable to induce mammary tumors in Syn1 null-mice, suggesting
that Syn1 is required for Wnt1 signaling (Alexander et al., 2000). In
Xenopus, Syn2 is required for the establishment of left-right
asymmetry (Kramer and Yost, 2002) and Syn4 regulates gastrula-
tion (Muñoz et al., 2006). During early development, Xenopus
syndecan1 (xSyn1) is expressed in the animal cap at the blastula
stage and later is excluded from the neural plate and restricted to
the non-neural ectoderm (Teel and Yost, 1996), similar to the
expression of BMP4 (Fainsod et al., 1994). Although exhibiting a
dynamic expression pattern, the role of xSyn1 during early
development has not been addressed.
This study aims to address the function of Syn1 during early
Xenopus development. Through gain- and loss-of-function experi-
ments we have demonstrated that xSyn1 modulates BMP signaling
with a biphasic effect. At high concentrations xSyn1 mRNA blocks
BMP activity and at low concentration it increases BMP signaling.
This effect is speciﬁc for xSyn1 and seems to be independent of its
GAG chains. In addition, morpholino knockdown of xSyn1 produced
an expansion of the neural plate and reduction of the non-neural
ectoderm. In summary, we have found that xSyn1 regulates dorso-
ventral patterning of the ectoderm through modulation of BMP
signaling.
Materials and methods
Embryos and explants
Xenopus embryos obtained by in vitro fertilizationweremaintained
in 0.1× modiﬁed Barth saline solution (Sive et al., 2000, Moreno et al.,
2005) and staged according to Nieuwkoop and Faber (1967).
Ectodermal explants were excised at stage 9 and cultured in 1×
modiﬁed Barth saline until sibling embryos reached the required
stage. Dorsal and ventral marginal zones were dissected in 1×modiﬁed Barth saline solution (Sive et al., 2000) and directly lysed
for RNA preparation. The dorsoanterior index (DAI) was estimated at
stage 33 according to Kao and Elinson (1988). In situ hybridization
was performed onwhole embryos as described (Lemaire and Gurdon,
1994; Belo et al., 1997; Sive et al., 2000; http://www.hhmi.ucla.edu/
derobertis/index.html). For lineage tracing of injected cells, 50 pg of
lacZmRNAwas co-injected and visualized by Red-Gal staining. Digital
photographs were taken with a Nikon Digital Sight DS-5M digital
camera.
Morpholino oligos
AntisenseMO forXenopus laevis xSyn1were obtained fromGene Tools
LLC and consisted of the following sequences: xSyn1.1 MO, 5′-
TTGTCCATCGTATCAGTGTGC-GCTG-3′; xSyn1.2 MO, 5′-ACAGGGCAACCA-
ATAACTTGTCCAT-3′. Bmp4 and Bmp7 MOs (Reversade et al., 2005);
Chordin MOs (Oelgeschlager et al., 2003); Noggin MO (Kuroda et al.,
2004); β-catenin MO (Heasman et al., 2000); xSyn4 MOs (Muñoz et al.,
2006) were as described. MOs were resuspended in sterile water to a
concentration of 1 mM. For xSyn1 MOs, a 1:1 ratio of both morpholinos
was used. A total of 4 nl (two times 2 nl) of morpholino solutions was
injected at the two-cell stage or 8 nl (two times 4 nl or four times 2 nl) of
morpholino solution injected at the four-cell stage.
RNA Injections
All mRNAs were synthesized in vitrowith SP6, T7 or T3 polymerase
using the Message Machine kit (Ambion Inc.). For β-catenin MO
rescue assays, capped mRNAs with or without additional MOs were
microinjected into the equatorial region at four-cell stage.
BMP reporter assay in embryos
BMP activity was evaluated in embryos with two BMP-speciﬁc
luciferase reporters: Msx2-luc (Sirard et al., 2000) and 4XBRE-luc
(Korchynskyi and ten Dijke, 2002). For reporter assays, embryos were
microinjected twice into animal region at two-cell stage with plasmid
reporter and mRNAs and/or morpholinos. Ectodermal explants from
15 embryos were excised at stage 9 and cultured in 1× modiﬁed Barth
saline solution until sibling embryos reached stage 11 and directly
lysed in groups of ﬁve explants (using 20 μl Reporter Lysis Buffer/
explant).
Protein analysis
Phospho-protein extracts were obtained as described (Birsoy et
al., 2005) with some modiﬁcations. Brieﬂy, protein extracts were
prepared from batches of 10 embryos using 10 μl homogenization
buffer/embryo. Homogenization buffer for anti-phospho-Smad1
blots was 20 mM Tris pH 8.0, 2 mM EDTA, 5 mM EGTA, 0.5% NP-
40, 2 mM sodium orthovanadate, 100 mM NaF, 10 mM sodium
pyrophosphate containing protease inhibitors. Homogenates were
spun down at 15,000 g for 10 min and the supernatant was
collected. 15 μl of samples were mixed with 7 μl of sample buffer.
Samples were boiled and loaded on 10% SDS-PAGE gels and
transferred into PVDF membranes. The membranes were blocked
for 1–2 h at room temperature. Anti-Phospho-Smad1 antibody (Cell
Signaling Technology) was used at a dilution of 1:2000. As a loading
control, membranes were stripped after signal detection, and
incubated with anti-Smad1 antibody (Zymed) at a dilution of
1:1000. Signal detection was carried out using the PIERCE ECL
detection system.
Heparan sulfate proteoglycans were detected as described (Stein-
feld et al., 1996; Casar et al., 2004; Gutiérrez et al., 2006). Brieﬂy, 50–
100 ectodermal explants were obtained from embryos microinjected
with mRNAs or MOs and at gastrula stage were lysed with 10 mM Tris
Fig. 1. xSyndecan-1 rescues dorsal structures in ventralized embryos. (A, B) xSyn1
induces dorsal axes in Xenopus embryos. Four-cell stage embryos were microinjected
into the vegetal region of one ventral blastomere with synthetic mRNA for xSyn1
(400 pg). Embryos were allowed to develop until stage 22 and double axes quantitated.
(C, D) xSyn1 rescue dorsal structures in βcat-morphant embryos. Two-cell embryos
were microinjected in each blastomere with MO-βcat (17 ng total) and after one
cleavage, one blastomere was microinjected with different doses of xSyn1 synthetic
mRNA (6–100 pg). Embryos were allowed to develop until stage 33 and DAI was
determined (Kao and Elinson, 1988). The amounts of xSyn1 used for rescue of βcat-
morphant embryos have no effect on dorso-ventral patterning of wild type embryos.
Note that as little as 6 pg of xSyn1 mRNA partially rescued dorsal structures and that
more than 25 pg gave rise to hyperdorsalized embryos (blue). The graph is the average
of four independent experiments.
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homogenization buffer/explant). Homogenates were spun down at
15,000 g for 10 min and the supernatant was collected. 30 μl of
samples were treated with 0.5 mU heparitinase obtained from Fla-
vobacterium heparinum (Seikagaku, Japan) and separated by SDS-
PAGE on a 4–15% gradient gel. Proteins were transferred on PVDF and
subjected to western blot analysis with anti-Δ-heparan sulfate
monoclonal antibody (3G10 epitope, US Biologicals), named anti-Δ-
HS at a dilution of 1:2500. As a loading control, membranes were
stripped after signal detection, and incubated with anti-β-tubulin
antibody (Sigma) at 1:10,000.
RT-PCR
For RT-PCR analyses, RNA was pooled from ten ectodermal
explants, or three whole embryos. RT-PCR conditions and primers
are described at http://www.hhmi.ucla.edu/derobertis/index.html.
DNA constructs
To obtain full length Syndecan1 from Xenopus, gastrula stage cDNA
wasampliﬁedusing twopairs of primers: theﬁrst pairwasdirected to the
5′ coding sequence, containing an internal XhoI site: Fw 5′-ATGGA-
CAAGTTACTGGCT-3′ and Rv 5′-TTCATCATGCCCAATAAGCA-3′, the second
pair was directed to the 3′ coding sequence, containing an internal XhoI
site and a silentmutation into the EcoRI site (bolded nucleotides) present
near the stop codon: Fw 5′-TGGAATTTGAGGAGACAACTGA-3′ and Rv 5′-
CTACGCGTAAAACTCCCG-3′. Each PCR fragment was subcloned into
pGEM-T easy (Promega). Both clones were digested with EcoRI and
XhoI and ligated into pCS2 to obtainpCS2-xSyn1. xSyn1was excised from
thepCS2withEcoRI and ligated intopGEM-TeasyandpcDNA3.We found
that the mRNA prepared from pGEM-T easy was more active and was
used for all experiments. Flag-tagged full length xSyn1 was obtained by
PCR using the primers: Fw 5′-GGATCCACGGATGTGAGCGTGAGA-3′ and
Rv 5′-CTTCTCATGATGACCTGC-3′ and the product was subcloned into
pGEM-NChd-ﬂag excised with BamHI/XhoI. A truncated form of xSyn1
lacking the cytoplasmic domain (xSyn1-ΔC) was generated using the
followingprimer 5′-CATGTGGAGCTCTCAATAGAGCATAAACCCAAC-3′. For
functional analysis of GAG chains of xSyn1, pcDNA3.1-ﬂag-xSyn1
was used as template for oligonucleotide directed mutagenesis
(QuickChange Multi Site-Directed Mutagenesis Kit, Stratagene),
which was used to generate a mutagenic construct of xSyn1 in
which serines 34, 41, 43, 190, 244 and 497 were converted into
alanine (xSyn1-ΔGAG).
siRNA knockdown of Syn1 in C2C12 cells
siRNA against mouse Syn1 (siSyn1) (GenBankTM accession
number NM_011519.1, nucleotide annotation 1660GAGGTCTACTTTA-
GACAACTT
1680
) purchased from Ambion, Inc. was used in C2C12 cells
as described (McQuade et al., 2006). siSyn1 sequence was 5′-
AAGUUGUCUAAAGUAGACCTC-3′. 70,000 cells/well were plated in a
six-well plate. 24 h later, cells were transfected using LipofectA-
MINE2000 (Invitrogen) containing a mix of 50 nM siSyn1; 1.5 ng/μl
of BRE-luc and 0.1 ng/μl of control pRL Renilla luciferase plasmid in
OptiMEM I transfection medium (Invitrogen) lacking serum and
antibiotics. Control cells were transfected with a control oligonu-
cleotide provided by the manufacturer. 24 h after transfection, cells
were trypsinized and 10,000 cells/well were plated in a 96-well
plate. Cells were serum starved for 12 h. The next day cells were
induced with recombinant BMP4 (R&D Systems), and luciferase
activity was measured 1 day later. Luciferase assays were
performed using the Dual Luciferase Reporter Assay system
(Promega) as described. In parallel, Syn1 protein expression was
analyzed by western blot from homogenates of C2C12 transfected
with siSyn1.Results
Overexpression of xSyndecan1 mRNA rescues dorso-ventral patterning in
Xenopus ventralized embryos
To evaluate xSyn1 function, synthetic mRNA was prepared and
injected at the four-cell stage. We found that injection of 400 pg of
xSyn1 mRNA in one ventral and vegetal blastomere resulted in the
formation of partial secondary axes (Figs. 1A and B, 70%, N=103).
Axes with anterior structures (cement gland and eyes) were never
observed and the embryos died when amounts higher than 1 ng were
injected (data not shown).
Secondary axes in Xenopus embryos can be obtained by over-
expression of components of the Wnt/β-catenin or Nodal pathways
and by antagonizing the BMP signaling pathway (De Robertis et al.,
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(Alexander et al., 2000) and HS chains are necessary for Wnt11
signaling in Xenopus oocytes (Tao et al., 2005), we reasoned that
xSyn1 could induce double axes via increasing Wnt/β-catenin
signaling. To test this hypothesis we inhibited Wnt signaling in early
development by knockdown of β-catenin using morpholinos (Heas-
man et al., 2000) and evaluated the effect of xSyn1 in this background.
In the case that xSyn1 function to increase Wnt signaling, over-
expression of xSyn1mRNAwould have no effect on embryos depleted
of β-catenin. Xenopus embryos at the two-cell stage were micro-
injected in both blastomeres with morpholino against β-catenin (MO-
βcat, denominated βcat-morphant embryos in this manuscript) and at
the four-cell stage received a single injection of xSyn1 mRNA. We
found that microinjection of xSyn1 mRNA was sufﬁcient to rescue
dorsal structures in βcat-morphant embryos (Figs. 1C and D). β-
catenin knockdown resulted in completely ventralized embryos (80%
DAI=0, N=140) as described before (Heasman et al., 2000).
Microinjection of only 6 pg of xSyn1 mRNA partially restored dorsal
structures (60% DAI=1–2; 35% DAI=3–4, N=32) and higher doses
of the mRNA (50 pg) gave rise to hyperdorsalized embryos (30%Fig. 2. xSyndecan-1 rescue of dorso-ventral patterning in a cell non-autonomous manner. (
followed by one (1×, 40 pg of total mRNA) or four (4×, 80 pg of total mRNA) microinjection
stage 18, (H–K) 10 or (L) 20 andmolecular markers analyzed by in situ hybridization using pr
molecular markers observed by in situ hybridization analysis was very penetrant. All βcat m
N=12–15) and showed an expansion of sizzled (panel F, N=11). One injection of xSyn1 mR
4× microinjections induce radial expression of sox2 and chordin in 18% (N=11) and 71% (N
Embryos at two-cell stage were microinjected with MO-βcat in both blastomeres, followed b
develop, ﬁxed at stage 27 and stained for β-galactosidase. (N) Section of one embryo, showin
see the insert). (O) xSyn1 rescue of Spemann Organizer speciﬁc markers. Embryos at the two
of xSyn1 mRNA in all blastomeres at the four-cell stage. RNA was isolated at stages 9, 10.5 aDAI=8–10, N=124). In addition, a similar rescue effect was observed
when a cytoplasmic deletion construct for xSyn1 was injected (see
Supplementary information ﬁg. S1), indicating that the interaction of
Syn1 with intracellular signaling components is not required for its
dorsal rescue activity.
To further evaluate the ability of xSyn1 to rescue dorso-ventral
patterning, molecular markers were evaluated by in situ hybridization
and RT-PCR analysis. A single injection of xSyn1mRNA (40 pg) in βcat-
morphant embryos was able to restore the expression of dorsal
markers such as sox2, NCAM and α-actin (Figs. 2A–D and L) and
ventral markers including sizzled and msx1 (Figs. 2E–G and L) to
normal levels, but proved unable to do the same with cytokeratin (Fig.
2L). No effect on Xbrawas observed, suggesting that xSyn1 has no role
on mesoderm formation (Fig. 2L). Of note, microinjection of this
amount of xSyn1 mRNA in wild type embryos had no effect in the
levels of molecular markers analyzed by RT-PCR (Fig. 2L, compare
lanes 1 and 4). From these results we concluded that xSyn1 is active in
the absence of a functional Wnt pathway, indicating that its ability to
induce dorsal structures is independent of Wnt/β-catenin signaling.
This was conﬁrmed by the observation that overexpression of xSyn1A–L) Embryos at two-cell stage were microinjected with MO-βcat in both blastomeres,
s of xSyn1 mRNA at the four cell stage. Embryonic development was stopped at (A–G)
obes against (A–D) sox2, (E–G) sizzled and (H–K) chordin or by (L) RT-PCR. The rescue of
orphant embryos are completely devoid of sox2 and chordin expression (panels B and I,
NA is 100% efﬁcient in restoring dorso-ventral patterning (panels C, G and J, N=5–17).
=7) of the embryos, respectively. (M, N) xSyn1 acts in a cell non-autonomous manner.
y one microinjection of xSyn1 (40 pg) and lacZ (50 pg) at the four-cell stage, allowed to
g that of all dorsal tissues only notochord was stained with β-galactosidase (for details
-cell were microinjected with MO-βcat in both blastomeres, followed bymicroinjection
nd 11.5 and expression of organizer genes evaluated by RT-PCR.
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of Xnr3 and siamois (see Supplementary information ﬁg. S2), two
direct targets of the Wnt/β-catenin pathway. In addition, we found
that knockdown of β-catenin provides a sensitized background that
facilitates the visualization of xSyn1 function.
To gain insight into the mechanism of double axes induction by
xSyn1, we performed lineage tracing experiments. xSyn1 and β-
galactosidase (lacZ) mRNAs were co-injected marginally in one
blastomere at the four-cell stage in βcat-morphant embryos. Embryos
were raised until the tadpole stage and stained for the presence of
lacZ. The cells derived from the blastomere that received both mRNAs
(xSyn1/lacZ) were found mainly in the notochord and head
mesoderm (Figs. 2M, N), indicating that xSyn1 rescues dorso-ventral
patterning through a cell non-autonomous effect. These results were
very similar to those obtained in previous studies, where ventralized
embryos were rescued by overexpression of Spemann's organizer
genes, such as noggin and chordin (Smith and Harland, 1992; Sasai et
al., 1994). Due to the results discussed above, we decided to test the
ability of xSyn1 to induce Spemann's organizer genes. For this, we
evaluated the expression of organizer genes in βcat-morphant
embryos injected with xSyn1 mRNA. xSyn1 was able to rescue chor-
din, goosecoid and ADMP, although with a slight delay in comparison
towild type embryos (Figs. 2H–K, and O). Additionally, xSyn1was able
to induce ectopic expression of chordin in wild type embryos (seeFig. 3. Overexpression of xSyndecan1 inhibits BMP signaling. (A, B) Activation of BMP
microinjected in one blastomere at the four-cell stage with synthetic mRNAs for xSyn1 (20 p
embryos were raised until stage 25 and the presence of dorsal axes determined. The graph re
inhibits Smad-1 phosphorylation. Wild type or βcat-morphant embryos at the four-cell sta
mRNA) with xSyn1 mRNA, embryos were cultured until stage 10.5, homogenized and phosp
extracts from 64-cell stage embryos were used (lane 1). Note that xSyn1was able to decrease
embryos (compare lane 3 with 4 and 5). Total Smad1/5/8 was measured as loading control
stage in all blastomeres with BMP reporter plasmid (Msx-luc, 30 pg), BMP4 (75 pg) and x
luciferase activity determined.Supplementary information ﬁg. S3). In contrast, noggin was only
partially rescued and the levels of cerberus were not re-established
(Fig. 2O). These results indicate that xSyn1 can restore expression of
some Spemann's organizer components, suggesting that the ability to
rescue dorso-ventral patterning can be mediated by induction of
Spemann's organizer genes such as chordin.
Overexpression of xSyndecan1 reduces BMP signaling
Another possibility to induce secondary axis is through reduction
of BMP signaling. Since partial secondary axes induced by xSyn1 (Fig.
1B) were similar to those obtained when BMP antagonists were
injected (Larraín et al., 2000) and because the βcat-morphant
embryos are more sensitive to respond to BMP inhibition (Reversade
et al., 2005), we decided to test whether xSyn1 regulates dorso-
ventral patterning through a BMP-dependent mechanism. Since
rescue of dorsal structures in βcat-morphant embryos is a very robust
assay, we decided to perform experiments in this sensitized back-
ground. To test for the relationship between xSyn1 and BMP signaling,
we analyzed the effect of BMP pathway activation in the ability of
xSyn1 to rescue dorsal structures. βcat-morphant embryos were co-
injected at the four-cell stage with xSyn1 mRNA together with
increasing amounts of BMP4 or Smad1 mRNA, and the presence of
dorsal structures were evaluated at stage 25. We noted that BMP4 andsignaling counteracts rescue of dorsal axes by xSyn1. βcat-morphant embryos were
g) together with (A) BMP4 (serial dilution from 10–640 pg) or (B) Smad1 (37–150 pg),
presents the average of three and two independent experiments, respectively. (C) xSyn1
ge were microinjected one (1×, 40 pg of total mRNA) or four times (4×, 80 pg of total
horylated Smad1/5/8 (P-Smad1/5/8) analyzed by western blot. As a negative control,
Smad1 phosphorylation inwild type (compare lane 2 with 6 and 7) and βcat-morphant
. (D) xSyn1 inhibits BMP reporter activity. Embryos were microinjected at the four-cell
Syn1 (30–60 pg) or Chordin (48 pg) mRNA. Extracts were obtained at stage 10.5 and
343G.H. Olivares et al. / Developmental Biology 329 (2009) 338–349Smad1 mRNAs were able to counteract the rescue of dorsal axes by
xSyn1 in a dose-dependent manner (Figs. 3A, B).
In order to have a more direct measure of the effect of xSyn1 in the
BMP pathway, we evaluated the levels of Smad1 phosphorylation (P-
Smad1). Wild type and βcat-morphant embryos were microinjected
at the four-cell stage, one or four timeswith xSyn1mRNA, harvested at
gastrula stage and P-Smad1 levels evaluated. As expected, knockdown
of β-catenin resulted in increased levels of Smad1 phosphorylation
(Fig. 3C, compare lanes 2 and 3; Reversade et al., 2005), which were
reduced by overexpression of xSyn1 (Fig. 3C, compare lanes 3, 4 and
5). xSyn1mRNAwas also able to reduce the levels of P-Smad1 in wild
type embryos (Fig. 3C, compare lanes 2, 6 and 7).
We also tested the effect of xSyn1 on the Msx-luciferase reporter
that responds to the BMP signaling pathway (Sirard et al., 2000). Four-
cell stage embryos were co-injected four times into the equator with
DNA for Msx-luciferase and xSyn1 mRNA, raised until stage 10.5 and
luciferase levels measured. In agreement with the P-Smad1 analysis,
we found that xSyn1 can reduce the levels of luciferase activity (Fig.
3D), similar to the effect of chordin, a known BMP antagonist (Piccolo
et al., 1996). Furthermore, the ability of xSyn1 to induce chordin
expression (Figs. 2H–K, O and see Supplementary information ﬁg. S3)
can also be considered a read-out of BMP inhibition. It has been
described that BMP4 signaling inhibits chordin expression in zebraﬁsh
and Xenopus embryos (Delaune et al., 2005; Maegawa et al., 2006),
which we have conﬁrmed by microinjection of morpholinos against
BMP4/7 in βcat-morphant embryos (see Supplementary information
ﬁg. S4). Similarly, overexpression of xSyn1 increases chordin expres-Fig. 4. xSyndecan-1 inhibits BMP signaling in a Chordin-independent manner. (A) xSyn1 req
the four-cell stage with xSyn1 (25 and 100 pg) together with morpholino control (MOCo) or C
of embryos with dorsal structures. Graph summarized the average of two independent exp
signaling in a Chordin-independent manner. Embryos were co-injected in both blastomeres i
and xSyn1mRNA (15–60 pg). Ectodermal explants were excised at stage 9, developed until si
levels in ectodermal explants were analyzed by RT-PCR. WE: whole embryo. (C) Effect of Chor
co-injected four times at the four-cell stage with xSyn1 together with morpholino control (M
blot. (D) Effect of siSyn1 on BMP signaling in C2C12 myoblasts. C2C12 were co-transfected w
20 h and luciferase activity determined. The graph shows the average of three independentsion (see Supplementary information ﬁg. S4) suggesting that rescue of
chordin expression can be a consequence of the ability of xSyn1 to
block BMP signaling. In summary, gain-of-function experiments
showed that xSyn1 inhibits BMP signaling and functions upstream
to, or in-parallel with, BMP4 and Smad1.
The ﬁndings that overexpression of xSyn1 rescued dorsal struc-
tures and blocked BMP signaling raised the question about whether
these were direct or indirect effects of xSyn1. This is especially
relevant in view of the ability of xSyn1 to induce expression of chordin,
a secreted protein known for its ability to rescue ventralized embryos
through BMP antagonism (Sasai et al., 1994; Piccolo et al., 1996). To
test if the effect of xSyn1 in dorso-ventral patterning and BMP
signaling inhibition are dependent on chordin, we performed
experiments in the presence of chordin morpholinos (Oelgeschlager
et al., 2003).
First, we tested the importance of chordin for the rescue of dorsal
axes by xSyn1 mRNA. We found that xSyn1 was no longer able to
restore dorsal structures in chordin morphant embryos (Fig. 4A). This
was speciﬁc for chordin because morpholinos against noggin (Kuroda
et al., 2004) had no effect (see Supplementary information ﬁg. S5) in
agreement with the observation that noggin expression was not
rescued by xSyn1 (Fig. 2O). One possible explanation for the
requirement of chordin is that xSyn1 can make a ternary complex
with chordin and cooperate in the binding of BMP, similarly to the role
of twisted gastrulation Tsg (Oelgeschlager et al., 2000). In favor of this
hypothesis, chordin binds to HSPG on the cell surface, and depletion of
sulfated HS chains results in a reduction of its anti-BMP activity (Jasujauires Chordin to rescue dorsal structures. βcat-morphant embryos were co-injected at
hordin (MO-Chd). Rescue of dorsal axes was determined at stage 25 and expressed as %
eriments. Green bar corresponds to βcat-morphant embryos. (B) xSyn1 inhibits BMP
n the animal region at the two-cell stage with a BMP luciferase reporter (BRE-luc, 30 pg)
bling embryos reached stage 11 and luciferase activity determined. Inset: chordinmRNA
din knockdown in the ability of xSyn1 to inhibit P-Smad1. βcat morphant embryos were
OCo) or Chordin (MO-Chd), raised until stage 10.5 and P-Smad1 evaluated by western
ith siCo or siSyn1 together with BRE-luc reporter, incubated with recombinant BMP4 for
experiments.
344 G.H. Olivares et al. / Developmental Biology 329 (2009) 338–349et al., 2004). The formation of ternary complexes should result in
strong cooperative effect as has been described for Tsg and chordin/
sog (Oelgeschlager et al., 2000; Larraín et al., 2001; Scott et al., 2001).
To test for cooperativity, we co-injected xSyn1 mRNA and chordin
mRNA or protein and we evaluated dorsal phenotypes and molecular
markers. For all the conditions tested, no cooperativity between these
two molecules has been observed (see Supplementary information
ﬁg. S6 and data not shown). We concluded from these experiments
that xSyn1 requires chordin to rescue dorsal structures but no
cooperativity between these two molecules was demonstrated.
We then decided to evaluate the role of chordin in the ability of
xSyn1 to block BMP signaling. First, we took advantage of the fact
that chordin is not expressed in the animal cap to test the effect of
xSyn1 in activation of a BMP reporter. In this case, we used the BRE-
luciferase reporter, a synthetic promoter construct that is more
speciﬁc for BMP signaling than the Msx reporter (Korchynskyi and
ten Dijke, 2002). Embryos at the two-cell stage were injected two
times in the animal pole with the BRE reporter together with xSyn1
mRNA; animal caps were isolated at the blastula stage and luciferase
levels measured when sibling embryos arrived to stage 10.5. We
found that xSyn1 efﬁciently reduces the levels of luciferase in the
absence of chordin expression (Fig. 4B). In addition, the effect of
chordin knockdown on the ability of xSyn1 to block P-Smad1 was
tested. To evaluate this, βcat-morphant embryos were microinjected
at the four-cell stage with xSyn1 mRNA together with control or
chordin morpholinos and the levels of P-Smad1 were determined at
the early gastrula stage. xSyn1 was still able to reduce the levels of
P-Smad1 in chordin morphant embryos (Fig. 4C, compare lanes 2
and 4), though with less efﬁciency when compared to embryos not
injected with chordin morpholinos (Fig. 4C, compare lanes 3 and 4).
These results indicate that xSyn1 can inhibit BMP activity in the
absence of chordin.
To further probe the chordin-independent effect of xSyn1, we
performed experiments in a cell culture assay. C2C12 cells were
transfected with the BMP reporters (Msx and BRE-luciferase) together
with siRNA against mouse syndecan-1 (McQuade et al., 2006). After
2 days of transfection, cells were incubated with pure recombinant
BMP4 for 20 h and the levels of mSyn1 and luciferase were
determined. We found that Syn1 was reduced in siSyn1 transfected
cells and an increase in the BMP response was observed (Fig. 4D and
see Supplementary information ﬁg. S7). These results suggested that
in a different context than the embryo, Syn1 can exert an inhibitory
effect on BMP4, giving further support to the ability of Syn1 to inhibit
BMP signaling.
In summary, from the aforementioned results we were able to
conclude that xSyn1 requires chordin to restore dorso-ventral
patterning, but clearly demonstrated that xSyn1 inhibits BMP
signaling in a chordin-independent manner.
xSyndecan1 is required for proper BMP signaling in Xenopus embryos
The gain-of-function experiments demonstrated that xSyn1 mRNA
is sufﬁcient to inhibit BMP signaling but provide no evidence about
the necessity of xSyn1 for BMP signaling. To evaluate this, we
performed loss-of-function studies using morpholinos. Two morpho-
linos complementary to the ATG region were designed, synthesized
and tested.
First, we evaluated their effect on endogenous xSyn1 protein
levels. For this, we used an antibody that recognizes the neo-epitope
generated in the core protein of each HSPG after removal of the HS
chains with heparitinase (anti-ΔHS). Importantly, this antibody
recognizes all the HS modiﬁed core proteins present in the sample.
Because xSyn1 mRNA is known to be expressed in the animal cap
(Teel and Yost, 1996), both morpholinos were microinjected in the
animal pole in each blastomere right after appearance of the
cleavage furrow. At stage 8, animal caps were isolated, cultured untilstage 11 and endogenous HSPG detected using the anti-ΔHS
antibody. In two independent experiments, we have found that
the morpholinos against xSyn1 speciﬁcally reduced the levels of two
bands; one that migrated above the 200 kDa molecular weight
marker and the other one around 150 kDa (Fig. 5A, see arrow and
arrowhead, respectively). Importantly, no effect on the other HSPG
core proteins was observed (Fig. 5A, see bracket). Treatment with
morpholinos against HSPG results in speciﬁc reduction of different
core proteins when blots with anti-ΔHS antibody were performed.
For example, injection of morpholinos against xSyn4 speciﬁcally
reduced the band of approximately 34 kDa (Muñoz et al., 2006)
conﬁrming the speciﬁcity of this experimental approach. Of note,
the open reading frame of xSyn1 is almost twice the size of its
mouse orthologues, suggesting that it should run in SDS-PAGE with
an apparent MW of approximately 150 kDa (mSyn1 runs in SDS-
PAGE with an apparent MW of 75 kDa). This is in agreement with
the MW of the fast migrating band reduced by xSyn1 morpholino
knockdown (Fig. 5A, arrowhead). The slow migrating band reduced
by xSyn1 morpholinos (Fig. 5A, arrow) can be explained because of
the tendency of syn1 to form oligomers and run with apparently
higher molecular weights, something that has been reported for
mSyn1 (Ma et al., 2006).
Considering that overexpression of xSyn1 blocks BMP signaling
and that xSyn1 and BMP4 are expressed in the ectoderm, we
decided to test the effect of xSyn1 morpholinos on the activation of
the BRE-luciferase reporter in animal cap assays. Embryos were
injected at the early two-cell stage with morpholinos against xSyn1
together with BRE-luciferase, animal caps explanted, cultured until
stage 10.5 and luciferase activity was measured. We found that
each of the two different xSyn1-MO were able to reduce the levels
of luciferase (see Supplementary information ﬁg. S8). Inhibition of
BRE activity was rescued by injection of xSyn1 mRNA (Fig. 5B),
indicating that the effect of xSyn1 knockdown was speciﬁc.
Moreover, knockdown of xSyn4, a member of the syndecan family
involved in gastrulation and non-canonical Wnt signaling (Muñoz
et al., 2006), was not able to reduce the levels of BRE-luciferase
(Fig. 5C). In summary, xSyn1 knockdown is very speciﬁc and
reliable (Eisen and Smith, 2008) because (1) endogenous levels of
xSyn1, but no other HSPG, were reduced; (2) two different
morpholinos against xSyn1 gave the same effect; (3) BRE inhibition
was rescued by xSyn1 mRNA, and (4) no inhibition of BRE activity
was observed when xSyn4, another member of the syndecan
family, was knocked-down.
The reduction of the levels of BRE-luciferase in xSyn1 morphant
embryos suggests that xSyn1 is required for proper activation of the
BMP response. To determine the relationship between xSyn1 and
other components of the BMP signaling we performed epistatic
experiments with Smad1 and BMP4. We found that Smad1 mRNA
efﬁciently restores the levels of BRE-luciferase in animal caps when
xSyn1 was knocked-down (Fig. 5D), indicating that xSyn1 functions
upstream of intracellular components of the BMP signaling cascade
giving further conﬁrmation to our ﬁndings shown in Fig. 3B. Then, we
tested the effect of xSyn1 morpholinos on the ability of BMP4 to
induce the BRE reporter. In animal cap assays, injection of 10–20 pg of
BMP4 mRNA resulted in 6–7 fold induction of the BMP reporter, after
xSyn1 knockdown only a three fold induction was observed (Fig. 5E).
This result indicated that BMP4 requires xSyn1 to signal, sugges-
ting that Syn1 functions downstream BMP, perhaps as a cell-surface
co-receptor.
Gain- and loss-of-function experiments for xSyn1 in Xenopus
embryos produced an apparent paradox. Both, overexpression and
knockdown resulted in reduced BMP signaling suggesting that
xSyn1 can have a biphasic effect depending on its concentration.
Enhancement of growth factor signaling by overexpression of HSPG
is more clearly visualized when tested in cells that express low
levels of proteoglycans (Steinfeld et al., 1996). To directly
Fig. 5. xSyndecan1 is necessary for BMP signaling in Xenopus embryos. (A) Effect of xSyn1MO in endogenous protein levels. Embryos at the two-cell stage were microinjected in the
animal pole in both blastomeres with a mix of two morpholinos against xSyn1 (MOSyn1-1,2). Animal caps explants were excised at stage 9 and cultured until siblings reached stage
10.5, homogenized, treated with heparitinase and HSPGs detected by western blot using α-ΔHS. A short (left) and long (right) exposure of the same blot are shown. Note that
MOSyn1(1,2) reduced the amount of two bands (arrow and arrowhead) that run similarly to xSyn1 expected molecular weight but do not interfere with other HSPG core proteins
(bracket). Lanes 1,2 and 3,4 correspond to two independent experiments. Left panel: short exposure, right panel: long exposure. (B) Rescue of xSyn1 knockdown. Embryos were co-
injected at the two-cell stage in both blastomeres with the BMP reporter (BRE-luc, 60 pg) together with MOSyn1(1,2) and xSyn1mRNA. Animal caps were excised at stage 8, cultured
until stage 10.5 and luciferase activity measured. (C) Inhibition of BMP signaling is speciﬁc for xSyn1 knockdown. Embryos were injected with morpholinos against xSyn1 or xSyn4
(MOxSyn4) together with BRE-luciferase and then analyzed as above. (D) Smad1 restores BMP signaling when xSyn1 is knockdown. (E) xSyn1 is required formaximal BMP signaling.
(F) xSyn1 regulates BMP signaling in a biphasic manner. BMP activity was evaluated at different doses of xSyn1 mRNA (60 to 4 pg) in xSyn1 morphants embryos.
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signaling we injected different amounts of xSyn1 mRNA in xSyn1
morphant embryos, isolated animal caps and measured BRE
luciferase levels. We found that at high levels xSyn1 mRNA inhibits
BMP signaling (Fig. 5F), as shown before in wild type embryos (Figs.
3C, D and 4B). Importantly, when lower levels of the mRNA were
injected an increase (4-fold) in BMP signaling was observed (Fig.
5F). This result indicates that xSyn1 can have a dual effect on BMP
signaling, at high concentrations it inhibits and at low levels it
enhances BMP signaling.xSyndecan1 is necessary for proper patterning of the ectoderm
During late gastrula and neurula stage, xSyn1 is expressed in the
non-neural ectoderm and is completely absent from the neural plate
(Teel and Yost, 1996), similar to the expression of BMP4 (Fainsod et al.,
1994). This expression pattern suggests a function for xSyn1 in dorso-
ventral patterning of the ectoderm. To study the possible role of xSyn1
in this process, xSyn1 morphant embryos were ﬁxed at neurula stage
and patterning of the neural plate and non-neural ectoderm studied by
in situ hybridization for sox2 and cytokeratin, respectively. Reduction of
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concomitant reduction on the territories expressing cytokeratin (Figs.
6A–F). At tailbud stages, xSyn1 morphant embryos showed defects on
the epidermis (Figs. 6G–H, see arrows). If allowed to develop further,
these defects on the epidermis gets more extensive and tadpoles die
(data not shown). In summary, these results indicate that xSyn1 is
essential for proper dorso-ventral patterning of the ectoderm.
xSyndecan1 function is speciﬁc and independent of its GAG chains
One important question in proteoglycan biology is to understand if
differentHSPGhave speciﬁc functions andwhichdomains are involved
in those functions (core protein and/or GAG chains). To assess for
speciﬁcity, we compared the ability of xSyndecan4 (xSyn4), xGlypi-
can4 (xGly4) and xSyn1 to rescue βcat-morphant embryos. The effects
of different HSPG were evaluated using two assays: rescue of dorsal
structures and reduction of Smad1 phosphorylation. xSyn1 over-
expression was very efﬁcient but no effect for xSyn4 and xGly4 was
observed in these two assays (Figs. 7A and B). To discard the possibility
that no effect with xSyn4 and xGly4was obtained because these HSPG
were not synthesized, we studied if overexpression of their mRNAs
resulted in increased proteoglycan levels. For this, syntheticmRNAs for
each HSPG were microinjected in embryos at the four-cell stage, 100
animal caps isolated, homogenized at stage 10.5, incubated with
heparitinase and analyzed bywestern blotwith anti-ΔHS antibody.We
found that the three HSPG were synthesized after mRNA over-
expression (Fig. 7C). In conclusion, xSyn4 and xGly4, even though
efﬁciently synthesized after mRNA overexpression, were unable to
rescue dorsal structures and to block BMP signaling, suggesting that
these functions are speciﬁc for xSyn1 core protein or its GAG chains.
To evaluate the role of the GAG chains, we mutated the potential
GAG attachment sites present in the core protein of xSyn1. xSyn1Fig. 6. xSyndecan1 regulates dorso-ventral patterning of the ectoderm. (A–F) xSyn1 knockdo
cell stage were microinjected in both blastomeres with (A, D) control and (B, E) xSyn1 morp
and (D, E) cytokeratin performed. Neural plate width was measured at the half of the antero-
test showing that means vary signiﬁcantly with (C) pb0.01 and (F) pb0.05, respectively. The
xSyn1 is necessary for epidermal integrity. Embryos at the two-cell stage were microinject
tailbud stage. Arrows point where epidermis is affected in xSyn1 morphant embryos.contains six putative GAG sites, ﬁve of them are also present in
mouse and rat Syn1 (Zhang et al., 1995; Teel and Yost, 1996).
Surprisingly, a construct with the six putative GAG attachment sites
mutated was still able to rescue dorsal structures when injected in
βcat-morphant embryos (Fig. 7D) and to block BMP signaling as
efﬁciently as wild type xSyn1 (Figs. 7E, F). These results indicate that
the ability of xSyn1 to restore dorso-ventral patterning is speciﬁc to
this cell-surface HSPG and is independent of the integrity of its GAG
attachment sites.
Discussion
We have described, for the ﬁrst time, a role for Syndecan1 in BMP
signaling and dorso-ventral patterning of the ectoderm during early
development of the Xenopus embryo. Through gain- and loss-of-
function experiments we have demonstrated that xSyn1 can modulate
BMP signaling. Overexpression of xSyn1 mRNA resulted in BMP
inhibition and rescue of dorsal structures in ventralized embryos, an
effect that is independent of the presence of its six GAG attachment
sites. Morpholino knockdown reduced BMP activity in animal caps
and expanded the size of the neural plate with the concomitant
reduction of the non-neural ectoderm. Experiments in xSyn1
morphant embryos showed that xSyn1 can have a biphasic effect
dependent on its concentration; high levels can block and low levels
can enhance BMP signaling.
Because we found that overexpression of xSyn1 mRNA induces
chordin expression, it was important to study if the ability of this HSPG
to rescue axes and inhibit BMP was dependent on chordin. We clearly
demonstrated that restoration of dorso-ventral patterning was
completely dependent on chordin (Fig. 4A), but contrary to that,
xSyn1 can inhibit BMP signaling in the absence of chordin (Figs. 4B, C).
These seemingly opposed results can be reconciled because inhibitionwn increased neural plate wide and reduced non-neural ectoderm. Embryos at the two-
holinos (34 ng), raised until neurula stage and in situ hybridization against (A, B) sox2
posterior axes with ImageJ. Statistical analysis with Kruskal–Wallis test and Dunn's post
number of embryos used for each experimental point is indicated above each bar. (G, H)
ed in both blastomeres with control and xSyn1 morpholinos (34 ng) and raised until
Fig. 7. xSyndecan1 function is speciﬁc and independent of the integrity of its GAG attachment sites. (A) Rescue of dorsal structures is speciﬁc for xSyndecan1. βcat-morphant embryos
received one single microinjection at the four-cell stage with synthetic mRNAs for xSyn1, xSyn4 and xGly4 (5–80 pg) and the presence of dorsal structures was evaluated at stage 25.
Average of three independent experiments. (B) Inhibition of BMP signaling is speciﬁc for xSyndecan1. βcat morphant embryos were radially microinjected with 50 pg of xSyn1, xSyn4
and xGly4 and P-Smad1 levels evaluated in whole embryos at stage 10.5. (C) Biosynthesis of HSPG in Xenopus embryos. Embryos at four-cell stage were microinjected in all
blastomeres with 80 pg of xSyn1, xSyn4 and xGly4, ectodermal explants were excised at stage 9 and cultured until siblings reached stage 10.5. Total amounts of HSPGs were
determined by western blot using α-ΔHS that speciﬁcally recognized HSPG core proteins after heparitinase treatment. In embryos microinjetcted with xSyn1 mRNA an increase in
the amount of a low migration band (arrowhead) was observed (compare lanes 1 and 2). For xSyn4 (arrow) and xGly4 (asterisks) overexpression bands of the expected size were
detected. (D) xSyndecan1 GAGmutant can rescue dorsal structures. MO-βcat embryos weremicroinjected once at the four-cell stagewith 40–200 pg of xSyn1 and xSyn1-ΔGAGDNA
constructs and the presence of dorsal structures were evaluated at stage 25. Average of three independent experiments is shown. (E, F) xSyndecan1 GAG mutant can block BMP
signaling. Embryos were co-injected at the two-cell stage in both blastomeres with the BMP reporter (BRE-luc, 60 pg) xSyn1 and xSyn1ΔGAG mRNA in wild type (E) or xSyn1
morphants (F). Animal caps excised at stage 8, cultured until stage 10.5 and luciferase activity was measured.
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Delaune et al., 2005; Maegawa et al., 2006). The fact that xSyn1 is not
able to restore dorso-ventral patterning in chordin morphant
embryos, together with its expression pattern (Teel and Yost, 1996)
and the xSyn1 morpholino knockdown phenotypes, demonstrated
that xSyn1 has no role in Spemann Organizer function. Although the
physiological role of xSyn1 is not to establish dorso-ventral axes, it is
important to highlight that the rescue of ventralized embryos is still a
very powerful assay to identify genes involved in BMP signaling thatcould then give rise to study the more physiological roles of these
novel molecules.
The overexpression of xSyn1 mRNA in xSyn1 morphant embryos
revealed its biphasic effect. At high concentrations xSyn1 mRNA
blocks BMP activity and at low concentration it increases BMP
signaling (Fig. 5F). The fact that increased levels of BMP4 counter-
act the ability of xSyn1 to restore dorsal axis (Fig. 3A) suggests that
at high concentrations xSyn1 is upstream of BMP4, perhaps
functioning as a BMP sequester. When xSyn1 levels were reduced
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BMP4 was observed. We found that BMP4 is less active when co-
injected with xSyn1 morpholinos (Fig. 5E). This indicates that
xSyn1 is required to attain maximal BMP signaling, suggesting a
co-receptor function for this cell surface HSPG. Loss-of-function
studies in embryos only revealed the co-receptor function of BMP
and its inhibitory effect was not detected. Contrary to this,
reduction of Syn1 in C2C12 cells resulted in increased levels of
BMP signaling, revealing its inhibitory role (Fig. 4D). The different
roles of Syn1 in BMP signaling in embryos and C2C12 cells could be
explained by the different levels of expression of Syn1 in each
speciﬁc cell-type.
The ﬁnding that xSyn1 can have positive and negative effects on
BMP signaling depending on its concentration is reminiscent of other
secreted molecules involved in this pathway that have a dual or
biphasic effect on growth factor activity. One example is the case of
chordin/sog and Tsg that bind BMP4/dpp and form a ternary
complex that, depending on the presence or absence of the
metalloproteinase tolloid, can inhibit or enhance BMP signaling
(Oelgeschlager et al., 2000; Larraín et al., 2001; Ross et al., 2001;
Shimmi et al., 2005; Wang and Ferguson, 2005). Similarly, the BMP-
binding protein Cv2 can promote or block BMP signaling depending
on its concentration and the presence or absence of other BMP
binding components (O'Connor et al., 2006; Ambrosio et al., 2008;
Serpe et al., 2008). Biphasic modulators such as Tsg and Cv2 can be of
use to produce spatial bistability leading to generation of sharp step-
gradients and precise borders (Larraín et al., 2001; O'Connor et al.,
2006; Serpe et al., 2008). Here, we introduced Syn1 as a new player
in the extracellular regulation of BMP signaling and showed that it
also has a biphasic effect.
Biochemical and genetic studies have demonstrated that BMP
binds to HS chains and heparin (Ruppert et al., 1996; Groppe et al.,
1998; Ohkawara et al., 2002; Lin, 2004), indicative of a signal-
regulating interaction. Our ﬁnding that xSyn1 function in Xenopus
embryos is independent of its GAG attachment sites agrees with
recent evidences of GAG independent functions for many HSPG
(Ohkawara et al., 2003; Lin, 2004; Kirkpatrick et al., 2006; Capurro et
al., 2008;). Of note, GAG-dependency changes during development,
HS chains are completely required for BMP/dpp signaling in the wing
imaginal disc but not for early embryonic dorso-ventral patterning
(Haerry et al., 1997; Han et al., 2004; Bornemann et al., 2008). From
these observations and our results, we propose that Syndecan1 can
modulate BMP signaling in a GAG independent-manner.
The defects on the epidermis of xSyn1 morphant embryos suggest
that xSyn1 is essential for ectodermal development. This could be
explained because of defective patterning of the ectoderm or could be
related to the function of Syn1 in cell adhesion and its interactionwith
integrins (Beauvais et al., 2004). This late effect of xSyn1 is of
particular interest because gene-targeting of Syn1 gives rise to mice
with normal embryonic development but defective wound healing
(Gallo et al., 1996; Park et al., 2001; Gotte et al., 2002; Stepp et al.,
2002). Studying the effect of xSyn1 in Xenopus could provide an
interesting model to study ectodermal differentiation and wound
healing.
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